Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Exiqon Launches Two New Research Use Only Kits
Friday, December 19, 2014
The miRSIGN™ miR-21 Oncogene assay and the miRSIGN™ Colon Cancer assay for PCR analysis of colon cancer samples.

INTEGRA Focus on Liquid Handling at SLAS 2015
Tuesday, December 16, 2014
INTEGRA's VIAFLO 96 and VIAFLO 384 benchtop electronic pipettes will be on display.

Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.

Low Profile 96-well Deep Well Plate
Monday, December 15, 2014
Porvair Sciences low profile 96-well deep well plate achieves a storage volume of 1.1ml / well in a height of just 27 mm enabling more plates to be stacked or stored in a given space.

SLAS2015 Liquid Handling Short Course
Saturday, December 13, 2014
SLAS partners with Artel to develop new “Liquid Handling Essentials” short course.

New Flexi-block Accessory from Techne
Saturday, December 13, 2014
Delivers new efficiency in sample heating.

Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress
Friday, December 12, 2014
Data from comparative 3D versus 2D study presented by Genentech at 2nd Annual FAST Congress.

Leica Microsystems Previews Light Sheet Module for Confocal Microscope
Tuesday, December 09, 2014
Technology preview at ASCB annual meeting.

BioTek Introduces Cytation™ 5 Cell Imager at ASCB 2014
Thursday, December 04, 2014
ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2616
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn